Status:
COMPLETED
Pain Diabetic Peripheral Neuropathy（DPN) in China
Lead Sponsor:
Peking University Third Hospital
Conditions:
Diabetic Neuropathies
Eligibility:
All Genders
18+ years
Brief Summary
To understand the clinical characteristics of DPN patients in China; To investigate the distribution of DPN patients with depression and anxiety symptoms; To investigate the related factors of moderat...
Detailed Description
Pain diabetic peripheral neuropathy (DPN) is a heavy global economic burden. An American observational study in 2013 showed that the total average annual adjusted direct medical cost/person for DPN pa...
Eligibility Criteria
Inclusion
- outpatients who are elder than 18 years old with history of type 1or type 2 diabetes
- The presence of symptoms, signs and/or electrophysiological evidence of diabetic peripheral neuropathy
- The patient presents spontaneous pain (continuous or intermittent acupuncture pain, electric shock pain, burning pain, etc.) or induced pain (sensory hypersensitivity, paresthesia, etc.)
- The pain lasts for at least 3 months
- Informed consent has been signed
Exclusion
- Patients with other causes of neuropathic, non-neuropathic, or mixed pain: for example, cervical/lumbar degenerative diseases, arthritis, nerve root compression, paraneoplastic syndromes, cerebrovascular diseases, spinal diseases, other peripheral neuropathies (immunological, toxic, nutritional peripheral neuropathies, etc.)
- Dementia, substance abuse, etc., severely affect cognitive and communication skills
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04456465
Start Date
April 1 2018
End Date
October 1 2018
Last Update
July 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, China